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ABSTRACT 
 
Cleft lip and palate is a congenital defect which arises from the interplay of multiple genetic and environmental factors. 
Dysmorphogenesis and abnormal growth is the most exciting of the challenges we face today as we strive to understand 
how environmental influences interact with and cause changes in the expression of the genetic factors governing the 
behavior of those cells which will give rise to the entire human body, and especially the face and palatal regions. The 
treatment of defective genes is very much a part of the current clinical agenda dealing with craniofacial defects. The basic 
scientist, the dysmorphologist, the clinician, and, importantly, those with natural or acquired craniofacial defects have 
gained significant advantage from the critical use of available information coming from classical and experimental studies 
of human morphogenesis. These advantages will continue to increase as laboratory scientists and clinician scholars move 
rapidly together into the world of molecular and gene biology. This article highlight the overview of genes that are 
possibly responsile for the formation of Cleft lip with or without cleft palate. 
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Introduction  
 
Orofacial clefts represent a common class of congenital 
malformations and are a major public health concern. 
The worldwide prevalence of clefts has been estimated 
as approximately 1 in every 1000 newborns, a figure 
that is higher in certain ethnic groups[1]. Orofacial 
clefts can occur as part of complex malformation 
syndromes, or as an isolated anomaly, also called non-
syndromic clefting. According to the National centre 
on Birth Defects and Developmental Disabilities 
(NCBDDD), birth defects affect about 1 in every 33 
babies born in the United States each year[2]. They are 
the Leading cause of infant deaths, accounting for more 
than 20% of all infant deaths. Cleft lip with/without 
cleft palate (CL/P), collectively termed oral clefts, are 
the Second most commonly observed birth defects 
among newborns after congenital heart defect. 
Craniofacial development is one of the most 
complex and tightly controlled events during 
embryonic development. Disturbances during this 
period, which is critical for the formation of face (4-10 
weeks for humans) may lead to orofacial clefts[3]. 
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Affected infants experience feeding difficulties during 
early weeks of life, resulting in nutrition problems and 
weight loss[4]. A study conducted in Swedish infants 
born between 1973 and 1992 showed that those 
affected with cleft lip and palate were lighter and 
shorter as compared with unaffected controls 
subjects[5]. Even after treatment affected individuals 
experience various health and psychosocial problems 
for e.g. higher risk for chronic otitis media, which may 
lead to conductive hearing loss[6]. Additionally, 
significantly increased lifetime mortality is associated 
with non-syndromic CL/P. A long-term follow-up 
study of 5331 Danish individuals with Non-syndromic 
cleft lip with/without cleft palate (NS CL/P) found a 
standardized mortality ratio of 1:4 for males and l:8 for 
females[7].Rare syndromes with oral clefts have 
distinct genetic causes where as the more common 
non-syndromic form of clefting has a multifactorial 
etiology with both genetic and environmental 
components, challenging the identification of 
underlying etiologies. Studying genetic factors 
involved in cleft lip and palate is vital to better 
understand its underlying etiologies and to improve the 
diagnosis, treatment, prognosis and eventually 
prevention, of this devastating birth defect. 
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Candidate genes  
 
FOXE1 
 
FOXE1 is a member of the forkhead/winged helix-
domain transcription factor family, whose members are 
primarily involved in embryonic development. 
Targeted disruption of the mouse FOXEl gene results 
in cleft palate and thyroid malformation[8]. Loss-of-
function mutations within its forkhead DNA-binding 
domain were shown as the cause of the Bamforth-
Lazarus syndrome manifested by thyroid agenesis, 
choanal atresia, bifid epiglottis, spiky hair and cleft 
palate[9]. A meta- analysis of 13 genome-wide linkage 
studies showed a susceptibility gene on 9q22, in the 
vicinity of FOXEI also including other strong 
candidate genes. A recent mutation screening in NS 
CL/P cases detected missense mutations in two 
unrelated patients[10]. Subsequently, significant 
association between SNPs across FOXEI and NSCL/P 
has been detected in multiple populations; however no 
common coding variants have been identified, except a 
polymorphic polyalanine tract that shows no 
association with clefting. Efforts at identifying the 
causative variant(s) in the regulatory elements of 
FOXE1 are currently underway. 
 
MSX1 
 
Ablation of the murine muscle-segment Homeobox I 
(MSXI) gene resulted in a variety of craniofacial 
defects, including complete cleft of the secondary 
palate[11]. Subsequently, a nonsense mutation 
segregating with tooth agenesis and mixed clefting 
phenotype was found in an extended Dutch family 
suggesting that it also plays a role in human 
clefting[12]. Significant association between SNPs in 
MSX1 and NS CL/P and CPO was shown in different 
populations of diverse origin[13,14]. Direct sequencing 
of the MSX1 coding regions showed that mutations in 
MSXI could account for approximately 2% of NS 
CL/P cases[15]. However no common coding 
mutations have been identified. Mutation screening in 
two functionally characterized enhancer elements that 
drives MSX1 expression in the pharyngeal arch and 
facial ectoderm, revealed multiple very low-frequency 
variants at significantly conserved nucleotide positions, 
some of them only present in affected individuals. 
SUMO1 
SUMO1 gene is a 101 amino acid polypeptide involved 
in post-translational modification of a variety of 
proteins. SUMO1 haplo-insufficiency resulting from a 
balanced reciprocal translocation was found in a case 
with isolated unilateral cleft lip and palate. It is 
strongly expressed in the upper lip, primary palate and 
medial edge epithelium of the secondary palate in the 
mouse at E13.5 and SUMOl-deficient mice also have a 
cleft palate phenotype[16]. Ablation of the Eyal gene 
was shown to increase the incidence of cleft phenotype 
in mice in compound heterozygous state with SUMO1. 
 
TBX22 
 
Function impairing (nonsense, frame-shift, splice-site 
and missense) mutations in the T-box transcription 
factor gene TBX22 result in X-linked cleft of the 
secondary palate (CPX), usually associated with 
ankyloglossia or tongue-tie. Its expression was 
localized to the developing palatal shelves and the base 
of the tongue where the ankyloglossia is observed. A 
previous genome-wide linkage analysis in NS CL/P 
families identified a susceptibility locus in the TBX22 
vicinity suggesting that the linkage signal may arise 
from this gene. In addition, mutations inTBX22 were 
also found in individuals with isolated CPO[17]. A 
recent study using an array of in-vitro functional assays 
demonstrated that TBX22 functions as a transcriptional 
repressor, and pathogenic missense mutations in the 
DNA-binding domain disrupt its DNA binding affinity 
and impairs its repression ability[18]. One interesting 
finding in this study was that regardless of the type and 
position of these missense mutations, they all 
compromised post-translational modification in 
SUMO1 gene translated protein. 
 
GSTT1 
 
The most well-established gene-environment 
interaction involved in human birth defects is the 
interaction between the null allele of glutathione S-
transferase theta-l gene (GSTT1) and maternal 
smoking in orofacial clefting. GSTT1 is involved in the 
second phase of the detoxification pathway and it is 
highly expressed in embryonic craniofacial structures. 
In a case-control study, reported increased risk of 
orofacial clefting when mothers carry the GST77-null 
genotype and smoke cigarettes or when both mothers 
and infants carry the null genotype and mothers smoke. 
A recent comprehensive study on a well-defined, large-
sample size from Iowa and Denmark identified 
significantly elevated risk for orofacial clefting in 
individuals with GSTT1-null genotype and whose 
mothers smoke during pregnancy ,whereas the 
association with either G5Tri-null allele or smoking 
was relatively less significant, demonstrating a clear 
gene-environment interaction[19]. 
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TGFA 
 
Significant interaction between the Taql site marker in 
the TGFA gene and smoking in isolated clefting was 
established[20]. The rare C2 allele of Taql site showed 
no association with clefting alone, however 
significantly increased risk of CPO among infants 
carrying the C2 allele was observed if the mother 
smoked during pregnancy suggesting potential gene-
environment interaction[36]. 
 
Interferon Regulatory Factor 6 (IRF6) 
 
IRF6 belongs to a family of transcription factors that 
share a highly conserved winged-helix DNA binding 
domain with a penta-tryptophan motif characteristic of 
IRF family. IRF6 consist of 467 amino acids encoded 
by a 4.3 kb transcript transcribed from 9 exons on the 
chromosomal arm 1q32. All IRF members bind to a 
consensus DNA-binding motif, called the Interferon 
stimulatory Response Element (ISRE), found mostly 
upstream of genes activated upon viral infection[21]. 
To date, nine members of this family of transcription 
factors have been described. All IRF members, except 
IRF6, have been implicated in interferon and immune 
response regulation, as evidenced by a series of 
knockout mouse studies[22]. However, the role of IRF6 
in immune regulation is not yet known. IRF6 has also 
been shown to bind to consensus ISRE motif, although 
its in vivo targets have yet to be determined. IRF6 was 
shown to interact directly with mammary serine 
protease inhibitor (maspin), a tumor suppressor 
involved in highly metastatic forms of breast cancer, 
through its protein binding domain called IRF 
association domain (IAD or SMAD-IRF). Furthermore, 
a recent study demonstrated that IRF6, in collaboration 
with maspin, promotes mammary epithelial cell 
differentiation by facilitating entry into cell cycle 
arrest[23]. IRF6 is strongly expressed in the ectoderm 
covering developing facial primordia and in the medial 
edge epithelia of the secondary palatal shelves[24]. 
Human and murine IRF6 show high degree of 
evolutionary conservation. Mice deficient for both 
alleles of IRF6 develop abnormally thick skin with 
severe limb and craniofacial abnormalities, including 
cleft of the secondary palate[25]. However, mice 
heterozygous for the null allele show no apparent 
phenotype except occasional intraoral adhesions in 
only 4% of embryos. The thick skin in mutants has 
been shown to result from an excessive proliferation of 
the spinous layer and a failure of keratinocyte terminal 
differentiation, suggesting that IRF6 plays an important 
role in keratinocyte proliferation and differentiation. 
Lack of the outrnost cornified layer of the skin exposes 
the underlying hyper-proliferated and fusion-competent 
spinous layer which is thought to promote abnormal 
adhesions between adjoining tissues, particularly in the 
oral cavlty. The intra-oral adhesions in the knockout 
mice were observed between the epithelia covering the 
maxillary and mandibular prominences in the region of 
the molar tooth. Mice carrying the most common 
mutation (R84C) observed in PPS also develop hyper-
proliferative skin and oral adhesions[26]. The inta-oral 
adhesions in these mice were detected between the 
epithelia covering the floor of the mouth and the 
ventral surface of the anterior tongue. Similarly, 
heterozygous embryos for the R84C mutation did not 
exhibit such adhesions. The clefting phenotypes 
observed in these mice seems to be caused by a failure 
of the palatal shelf elevation. These studies further 
suggest that the oral adhesions or compression of the 
oral cavity due to thickened skin prevent palatal shelf 
elevation resulting in the cleft of the secondary palate. 
The significant overlap in the phenotype between VWS 
and NS CL/P, IRF6 was assessed as a potential 
candidate gene for NS CL/P. In 2005 Scapoli and 
others reported significant association between SNPs 
scattered over ~140 kb haplotype block encompassing 
IRF6 and NS CL/P in 1968 families from l0 distinct 
populations with an ancestry in Asia, Europe, and 
South America[27]. In particular, a non- synonymous 
variant that changes a highly conserved valine residue 
to isoleucine at amino position 274 (rs2235371,V274I), 
showed the most significant association in the entire 
dataset, the association in individuals of Asian and 
South American origin was particularly highly 
significant. Subsequently 5 additional studies 
independently replicated this association in additional 
populations from Europe and Asia[28,29].Based on the 
Scapoli et al. study, genetic variation in IRF6 has been 
estimated to be responsible for l2% of the genetic 
contribution to NS CL/P and tripled the recurrence risk 
in families with an affected child[34]. The associated 
allele of V274I is the evolutionarily conserved V allele 
which has a frequency of over 97% in European 
populations and ~99.5% in Africans, making this SNP 
an unlikely factor for disease susceptibility. Direct 
sequencing of 160 individuals with NS CL/P revealed 
no other coding or splice site variants. Therefore, the 
etiological variant(s) in IRF6 remained elusive[37]. 
 
Other Candidate Gene 
 
In addition to these extensively studied genes and 
pathways that we reviewed here, preliminary evidence 
for a number of other genes exists supporting their role 
in NS CL/P. One recently identified gene associated 
with NS CL/P is CRISPLD2, with strong expression in 
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the fusing palatal shelves[30]. Ectopic expression of 
TBXl0 in transgenic mice results in cleft lip and palate 
and mutations in TBX10 were also detected in 
individuals with NS CL/P. Similarly, overexpression of 
the Sprouty2 gene causes stage-dependent craniofacial 
defects in transgenic mice. Mutations in human 
Sprouty 2 further delineates its role in cleft lip and 
palate[35]. Heterozygous mutations in p63 gene are 
responsible for the autosomal dominant ectrodactyly, 
ectodermal dysplasia with facial clefts (EEC)[31,32] . 
A de-novo missense mutation that disrupt a functional 
domain of p63 has recently been found in a NS CL/P 
patient[38]..  
 
Conclusion 
 
Non-syndromic cleft lip with or without cleft palate 
(CL/P) is the most common craniofacial anomaly.  The 
number of causative genetic loci is estimated to be 
between 2 to l4. One of the candidate gene contributing 
to CLIP, has been identified as IRF6. It was initially 
targeted for investigation after mutations were detected 
in the gene in patients with Van der Woude syndrome, 
an Autosomal dominant disorder characterized by cleft 
lip, cleft palate, and pits in the lower lip. Recent studies 
have suggested that DNA sequence variants associated 
with IRF6 are major contributors to non-syndromic 
CL/P in multiple human populations. 
 
Future directions 
 
The completion of the genome sequence has 
contributed to recent successes in identifying   novel 
CL/P genes. The direct study of non-syndromic CL/P 
has previously been hampered due to the general lack 
of well-defined multiplex families with sufficient 
power to enable a genome-wide linkage study to 
provide a localization. The use of model organisms and 
in particular the mouse, has for some time been a rich 
source of information for craniofacial development. 
Transgenic and knockout technology has often, and 
sometimes quite unexpectedly, provided a long list of 
genes that confer an CL/P phenotype. The number and 
diversity of targeted genes that result in a cleft 
probably reflects why CL/P is one of the most common 
features seen in human birth defects. The use of mutant 
inbred strains to tease out causative genes and provide 
models is an exceptionally powerful tool. Nevertheless, 
the problem is to directly relate them to the complex 
human situation where genetic heterogeneity and 
varying environ- mental/socio-economic status is 
found. 
               Our general failure to pinpoint the precise 
molecular events that lead to human CL/P most likely 
stems from our lack of knowledge about the gene 
networks and regulation of gene expression during 
palatal development. Clearly we are now in a far better 
position to address this. We now have knowledge of 
several genes that play strong genetic roles in human 
craniofacial development and contribute to the 
incidence of non-syndromic CL/P. These genes will 
provide tools to study and elucidate the genetic 
pathways that they function in. This can be combined 
with a second powerful approach, using the latest 
generation of expression profiling techniques. In 
conjunction with the genome sequence and virtually a 
complete list of genes, detailed information about the 
genes that are expressed and those that are switched on 
or off at different stages of craniofacial development 
can be determined. 
Recent examples of this are the ongoing studies of 
COGENE, where expression profiling using both 
microarray and SAGE technologies are being used to 
generate profiles of a variety of human orofacial 
structures between 4 and 8.5 weeks of development. 
Similarly, a recent study from Brown et al. used 
microarray analysis to look at expression profiles of 
mouse vertical, horizontal and fused (El3.5, 14.5 and 
15.5) palatal shelves. An altemative approach has been 
reported by who performed a subtractive hybridization 
screen to enrich for E10.5 mouse embryonic branchial 
arches 1 - and 2-specific genes. The validity of this 
approach was demonstrated by identifying a variety of 
genes with established roles in craniofacial 
development in a random sampling. 
There is now every reason to be optimistic about our 
future understanding of human CL/P whilst syndromic 
gene mutations may contribute no more than l0% to 
non- syndromic CL/P, these findings will lead to a 
better understanding of the gene pathways, interactions 
and novel candidates. For many, the benefits of precise 
diagnosis, accurate risk assessment and genetic 
counselling can be achieved. When integrated with 
tissue specific expression profiling and targeted 
developmental studies, the potential for treatments and 
preventative therapies may also become a reality. 
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